BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1328981)

  • 1. Visual field testing in the management of cytomegalovirus retinitis.
    Bachman DM; Bruni LM; DiGioia RA; Harris PJ; McMackin CM; Pistole MC; Thomas RM; Ward DJ
    Ophthalmology; 1992 Sep; 99(9):1393-9. PubMed ID: 1328981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
    Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG
    Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
    Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
    Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis.
    Geier SA; Klauss V; Matuschke A; Kronawitter U; Goebel FD
    Ger J Ophthalmol; 1992; 1(2):110-3. PubMed ID: 1335812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal disease associated with AIDS.
    Freeman WR
    Aust N Z J Ophthalmol; 1993 May; 21(2):71-8. PubMed ID: 8101447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
    Mansor AM; Li HK
    Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification.
    Keefe KS; Freeman WR; Peterson TJ; Wiley CA; Crapotta J; Quiceno JI; Listhaus AD
    Ophthalmology; 1992 Sep; 99(9):1377-84. PubMed ID: 1328980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of cytomegalovirus retinitis.
    Bloom JN; Palestine AG
    Ann Intern Med; 1988 Dec; 109(12):963-9. PubMed ID: 2848436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir.
    Anand R; Font RL; Fish RH; Nightingale SD
    Ophthalmology; 1993 Jul; 100(7):1032-9. PubMed ID: 8391675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus retinitis in AIDS.
    Wilson RJ
    J Am Optom Assoc; 1992 Jan; 63(1):49-58. PubMed ID: 1316393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of cytomegalovirus retinitis.
    Henderly DE; Jampol LM
    J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S6-10. PubMed ID: 1848624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
    J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Palestine AG; Polis MA; De Smet MD; Baird BF; Falloon J; Kovacs JA; Davey RT; Zurlo JJ; Zunich KM; Davis M
    Ann Intern Med; 1991 Nov; 115(9):665-73. PubMed ID: 1656826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine and cytomegalovirus retinitis.
    Carter JE; Shuster AR
    Ann Ophthalmol; 1992 May; 24(5):186-9. PubMed ID: 1322108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus retinitis complicated by optic neuropathy: a longitudinal study.
    Harkins T; Maino JH
    J Am Optom Assoc; 1992 Jan; 63(1):21-7. PubMed ID: 1316391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.